CF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%

Bulletin Express06-12

CF PharmTech, Inc. repurchased 14,000 H-shares on 12 June 2026 through on-market transactions in Hong Kong. The shares were bought at prices ranging from HKD 17.83 to HKD 18.15, with a volume-weighted average cost of HKD 17.98, bringing total consideration to approximately HKD 0.25 million.

Following the transaction, issued shares (excluding treasury shares) decreased to 300.84 million, while treasury shares rose to 1.38 million. The repurchase reduced the company’s outstanding share capital by 0.0047%.

The buyback forms part of a mandate approved on 16 December 2025, which authorises the company to repurchase up to 30.22 million shares. Cumulative repurchases under this mandate now stand at 1.38 million shares, representing 0.46% of the issued share count as at the mandate date.

In line with Hong Kong listing regulations, CF PharmTech is subject to a moratorium on issuing new shares or disposing of treasury shares until 12 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107485359?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-12 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107485359","market":"hk","top_or_hot":-1,"title":"CF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%","media":"Bulletin Express","content":"<p>CF PharmTech, Inc. repurchased 14,000 H-shares on 12 June 2026 through on-market transactions in Hong Kong. The shares were bought at prices ranging from HKD 17.83 to HKD 18.15, with a volume-weighted average cost of HKD 17.98, bringing total consideration to approximately HKD 0.25 million.</p>\n<p>Following the transaction, issued shares (excluding treasury shares) decreased to 300.84 million, while treasury shares rose to 1.38 million. The repurchase reduced the company’s outstanding share capital by 0.0047%.</p>\n<p>The buyback forms part of a mandate approved on 16 December 2025, which authorises the company to repurchase up to 30.22 million shares. Cumulative repurchases under this mandate now stand at 1.38 million shares, representing 0.46% of the issued share count as at the mandate date.</p>\n<p>In line with Hong Kong listing regulations, CF PharmTech is subject to a moratorium on issuing new shares or disposing of treasury shares until 12 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-12 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech, Inc. repurchased 14,000 H-shares on 12 June 2026 through on-market transactions in Hong Kong. The shares were bought at prices ranging from HKD 17.83 to HKD 18.15, with a volume-weighted average cost of HKD 17.98, bringing total consideration to approximately HKD 0.25 million.</p>\n<p>Following the transaction, issued shares (excluding treasury shares) decreased to 300.84 million, while treasury shares rose to 1.38 million. The repurchase reduced the company’s outstanding share capital by 0.0047%.</p>\n<p>The buyback forms part of a mandate approved on 16 December 2025, which authorises the company to repurchase up to 30.22 million shares. Cumulative repurchases under this mandate now stand at 1.38 million shares, representing 0.46% of the issued share count as at the mandate date.</p>\n<p>In line with Hong Kong listing regulations, CF PharmTech is subject to a moratorium on issuing new shares or disposing of treasury shares until 12 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1107485359","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107485359","pubTimestamp":1781264645,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech, Inc. repurchased 14,000 H-shares on 12 June 2026 through on-market transactions in Hong Kong. The shares were bought at prices ranging from HKD 17.83 to HKD 18.15, with a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech执行25万港元回购，自由流通量削减0.0047%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech, Inc. repurchased 14,000 H-shares on 12 June 2026 through on-market transactions in Hong Kong. The shares were bought at prices ranging from HKD 17.83 to HKD 18.15, with a volume-weighted average cost of HKD 17.98, bringing total consideration to approximately HKD 0.25 million.\nFollowing the transaction, issued shares (excluding treasury shares) decreased to 300.84 million, while treasury shares rose to 1.38 million. The repurchase reduced the company’s outstanding share capital by 0.0047%.\nThe buyback forms part of a mandate approved on 16 December 2025, which authorises the company to repurchase up to 30.22 million shares. Cumulative repurchases under this mandate now stand at 1.38 million shares, representing 0.46% of the issued share count as at the mandate date.\nIn line with Hong Kong listing regulations, CF PharmTech is subject to a moratorium on issuing new shares or disposing of treasury shares until 12 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107485359","isCrawlerRequest":true}